Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
GA is a form of age-related macular degeneration (AMD) that causes irreversible vision loss, affecting approximately 1.5 million people in the United States1,2 Eric and his mother, Jamey, are...
If approved, CRESEMBA will offer a new treatment option for pediatric patients facing certain invasive fungal infections NORTHBROOK, Ill., Aug. 10, 2023 /PRNewswire/ -- Astellas Pharma US, Inc....
Read more about U.S. FDA Accepts Astellas' sNDA for CRESEMBA® (isavuconazonium sulfate) in Children
Both Companies win a year of access to a prestigious life-science incubator in San Francisco, CA and to Astellas expertise to further their research Award helps biotech start-ups accelerate early...
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise for scientific innovators TOKYO and SAN FRANCISCO, Sept. 19, 2022 /PRNewswire/ --...
- Winner developed app to empower cancer patients after experience as a cancer caregiver - NORTHBROOK, Ill., Aug. 8, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the...
- 135,000 square-foot state-of-the-art gene therapy manufacturing facility located in Sanford, N.C., officially opened June 8 - Facility to support clinical- and commercial-scale manufacturing of...
- Addressing everyday challenges in cancer care; apply by June 3, 2022 - NORTHBROOK, Ill., April 25, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced that it is accepting...
- Vcreate and Weatherwax Biotechnologies win a year of access to life-science incubator in San Francisco, CA and to Astellas expertise to further their research - TOKYO and SAN FRANCISCO, Dec. 14,...
-Thymmune Therapeutics and M13 Therapeutics win a year of access to life-science incubator in Cambridge, MA and access to Astellas expertise to further their research- CAMBRIDGE, Mass., Nov. 3, 2021 /
Astellas ranked again in Seramount's 100 Best Companies and Best Companies for Dads lists. NORTHBROOK, Ill., Sept. 28, 2021 /PRNewswire/ -- Seramount (formerly Working Mother Media) revealed its...
Read more about Astellas Recognized Consistently Among Top Companies for Working Parents
Follow U.S. news
